EP. 1: An Overview of Myelodysplastic SyndromesByHetty Carraway, MD, Cleveland Clinic,Guillermo Garcia-Manero, MD, MD Anderson Cancer CenterDecember 17th 2020
EP. 2: Work-up of Myelodysplastic SyndromesByHetty Carraway, MD, Cleveland Clinic,Guillermo Garcia-Manero, MD, MD Anderson Cancer CenterDecember 17th 2020
EP. 3: Monocytosis in Myelodysplastic SyndromesByHetty Carraway, MD, Cleveland Clinic,Guillermo Garcia-Manero, MD, MD Anderson Cancer CenterDecember 17th 2020
EP. 4: Risk Assessment & Genetic Testing in Myelodysplastic SyndromesByHetty Carraway, MD, Cleveland Clinic,Guillermo Garcia-Manero, MD, MD Anderson Cancer CenterDecember 17th 2020
EP. 5: NGS in Myelodysplastic SyndromesByHetty Carraway, MD, Cleveland Clinic,Guillermo Garcia-Manero, MD, MD Anderson Cancer CenterDecember 17th 2020
EP. 6: Treatment Approach in Myelodysplastic SyndromesByHetty Carraway, MD, Cleveland Clinic,Guillermo Garcia-Manero, MD, MD Anderson Cancer CenterDecember 17th 2020
EP. 7: Therapy Options in Low-Risk Myelodysplastic SyndromesByHetty Carraway, MD, Cleveland Clinic,Guillermo Garcia-Manero, MD, MD Anderson Cancer CenterDecember 17th 2020
EP. 8: Treatment Goals in Myelodysplastic SyndromesByHetty Carraway, MD, Cleveland Clinic,Guillermo Garcia-Manero, MD, MD Anderson Cancer CenterDecember 17th 2020
EP. 9: Understanding the MEDALIST TrialByHetty Carraway, MD, Cleveland Clinic,Guillermo Garcia-Manero, MD, MD Anderson Cancer CenterDecember 17th 2020
EP. 10: Luspatercept in the Treatment of Myelodysplastic SyndromesByHetty Carraway, MD, Cleveland Clinic,Guillermo Garcia-Manero, MD, MD Anderson Cancer CenterDecember 17th 2020
EP. 11: Possible Treatment Options for Myelodysplastic SyndromesByHetty Carraway, MD, Cleveland Clinic,Guillermo Garcia-Manero, MD, MD Anderson Cancer CenterDecember 17th 2020
EP. 12: A Multidisciplinary Team in Treating Myelodysplastic SyndromesByHetty Carraway, MD, Cleveland Clinic,Guillermo Garcia-Manero, MD, MD Anderson Cancer CenterDecember 17th 2020
